Siegfried (SGFEF) Stock Price, News & Analysis

Company Overview

Siegfried Holding AG, trading over the counter as SGFEF, is a Switzerland-based contract development and manufacturing organization (CDMO) specializing in active pharmaceutical ingredients (APIs) and finished dosage forms. Founded in 1873 and headquartered in Zofingen, the company has grown from a regional chemical producer into a global partner for pharmaceutical and biotechnology firms. Over its more than 140-year history, Siegfried has expanded through strategic acquisitions and investments in research and production technologies to meet evolving industry needs.

The company’s core offerings include custom synthesis, process development and scale-up for small-molecule APIs, as well as commercial-scale API manufacturing. Siegfried also provides drug product services such as formulation development, clinical-trial manufacturing, fill-and-finish operations, blister packaging and secondary packaging. By integrating development and manufacturing capabilities under one roof, the firm aims to streamline supply chains, reduce time to market and ensure regulatory compliance for its customers worldwide.

Siegfried serves a diverse global customer base, supporting innovators, generic drug producers and niche biotech companies. Its manufacturing and development sites are located across Europe, North America and Asia, including facilities in Switzerland, Germany, the United States and China. This geographic footprint enables the company to offer flexible supply-chain solutions and responsive local service. Under the leadership of Chief Executive Officer Marco Mamone, Siegfried continues to invest in technological upgrades and capacity expansions to address growing demand for high-quality pharmaceutical manufacturing services.

Key Stats

• Today's Range: $104.61 to $104.61
• 50-Day Range: $104.61 to $114.35
• 52-Week Range: $102.50 to $114.35
• Volume: 100 shs
• Average Volume: 233 shs
• Market Capitalization: N/A
• P/E Ratio: 7.57
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Buy

Siegfried Stock Analysis - MarketRank™

Siegfried scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Siegfried.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Siegfried is 7.57, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 283.50.

Price to Earnings Ratio vs. Sector

The P/E ratio of Siegfried is 7.57, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 77.34.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Siegfried has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Siegfried has recently decreased by 0.97%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Siegfried does not currently pay a dividend.

Dividend Growth

Siegfried does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Siegfried has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Siegfried has recently decreased by 0.97%, indicating that investor sentiment is improving.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Siegfried this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Siegfried insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 19.09% of the stock of Siegfried is held by institutions.

SGFEF Stock Analysis - Frequently Asked Questions

How have SGFEF shares performed this year?

Siegfried's stock was trading at $965.00 at the beginning of 2025. Since then, SGFEF stock has decreased by 89.2% and is now trading at $104.61.

How do I buy shares of Siegfried?

Shares of SGFEF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:SGFEF
• CIK: N/A
• Web: www.siegfried.ch
• Phone: 41 62 746 1111
• Fax: N/A
• Employees: 3,819
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 7.57
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A